RT @anesthesiacamp: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shock an…
RT @YaseenarabiYa: RCT: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shoc…
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/8e6hXegrtE
RT @YaseenarabiYa: RCT: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shoc…
RT @YaseenarabiYa: RCT: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shoc…
RT @YaseenarabiYa: RCT: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shoc…
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/s8Rues5u1w
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/jvGPsFI2OP
RT @medicritica: Ni el haloperidol ni la ziprasidona mostraron disminución en el tiempo del delirium en #CuidadoIntensivo 🙁 lo visto en #LI…
El uso de Haloperidol o Ziprasidona no redujo la duración del delirio en pacientes ingresados en UCI. https://t.co/10O2AF5t4n
RT @ZiadKazzi: Toxicologists always knew that these were not the best options to treat delirium. Haloperidol and Ziprasidone for Treatment…
Two antipsychotic ineffective on delirium duration in ICU patients https://t.co/WjR5eIBZlr
RT @martinezvelilla: The use of haloperidol or ziprasidone did not significantly alter the duration of delirium @A_MacLullich @EDA_delirium…
RT @martinezvelilla: The use of haloperidol or ziprasidone did not significantly alter the duration of delirium @A_MacLullich @EDA_delirium…
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/K9mquKFDav
The use of haloperidol or ziprasidone did not significantly alter the duration of delirium @A_MacLullich @EDA_delirium https://t.co/yfW72cLTyF
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/hqQru3np9L
重症疾患におけるせん妄の治療のためのハロペリドールとジプラシドン Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness December 27, 2018 N Engl J Med 2018; 379:2506-2516 https://t.co/x1uAWdhqz6
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/GDYyg79UW7
El uso de haloperidol o ziprasidona en pacientes con insuficiencia respiratoria aguda o shock y delirio hipoactivo o hiperactivo en cuidados intensivos no alteró la duración del delirio https://t.co/MOL4C8ddOj
RT @ZiadKazzi: Toxicologists always knew that these were not the best options to treat delirium. Haloperidol and Ziprasidone for Treatment…
RT @PittStroke: Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/pQ6kBt6IOp
RT @YaseenarabiYa: RCT: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shoc…
RCT: The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the ICU did not significantly alter the duration of delirium. https://t.co/1MpwTkiKhB
The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the ICU did not significantly alter the duration of delirium. https://t.co/ncpbkCqeCq https://t.c
Toxicologists always knew that these were not the best options to treat delirium. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/7xgZYDwiQm @menantox @acmt @emoryem
Ni el haloperidol ni la ziprasidona mostraron disminución en el tiempo del delirium en #CuidadoIntensivo 🙁 lo visto en #LIVES2018 😱 llama la atención la alta incidencia del delirium y que la mayoría es hipoactivo (el más difícil de diagnosticar) 👇🏼https://
Delirium em paciente crítico: Haloperidol e Ziprasidona não mudam o quadro. O melhor ainda é a prevenção. https://t.co/3z4nukjWCx
#Haloperidol and #Ziprasidone for Treatment of #Delirium in Critical Illness | @NEJM #ICU https://t.co/a3X9JakCRW
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/pQ6kBt6IOp
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness? Nope. | NEJM https://t.co/aBOi3vRQ7w
RT @PabloRichly: Parece que es hora de empazar a dejar de usar antipsicóticos en delirium. https://t.co/KNSbjmTgPh
Interesting that about 90% of the ICU delirium was hypoactive! Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness | NEJM https://t.co/tVpXA76Iuh
Articles that will be discussed during tomorrow's #SCCM #Pharmacy #Journal Club. #Lacosamide vs. #fosphenytoin for nonconvulsive #seizure https://t.co/6LD1Vl0wm9 #Pantoprazole for #SUP https://t.co/mNSsZ1uUPs #Haldol and #ziprasidone for #ICU #delirium ht
RT @stephen_t_webb: #ICSSOA2018 FYI MIND-USA @DrDaleNeedham https://t.co/8curBnqQKa
RT @SOCCA_CritCare: See the original study here: https://t.co/YfHCWREQRs Better solutions for #ICU #delirium are needed. This study demonst…
RT @stephen_t_webb: #ICSSOA2018 FYI MIND-USA @DrDaleNeedham https://t.co/8curBnqQKa
RT @stephen_t_webb: #ICSSOA2018 FYI MIND-USA @DrDaleNeedham https://t.co/8curBnqQKa
RT @stephen_t_webb: #ICSSOA2018 FYI MIND-USA @DrDaleNeedham https://t.co/8curBnqQKa
RT @stephen_t_webb: #ICSSOA2018 FYI MIND-USA @DrDaleNeedham https://t.co/8curBnqQKa
#ICSSOA2018 FYI MIND-USA @DrDaleNeedham https://t.co/8curBnqQKa
See the original study here: https://t.co/YfHCWREQRs Better solutions for #ICU #delirium are needed. This study demonstrates the importance of preventative strategies and more systematic evaluation to assess if these interventions work & to develop ef
RT @iceman_ex: Top 6 Neuro- @celiabradford: DAWN https://t.co/RWKEHG09Hp DEFUSE 3 https://t.co/MLEelkIcvt Neurofilament light chain post…
RT @iceman_ex: Top 6 Neuro- @celiabradford: DAWN https://t.co/RWKEHG09Hp DEFUSE 3 https://t.co/MLEelkIcvt Neurofilament light chain post…
RT @iceman_ex: Top 6 Neuro- @celiabradford: DAWN https://t.co/RWKEHG09Hp DEFUSE 3 https://t.co/MLEelkIcvt Neurofilament light chain post…
Top 6 Neuro- @celiabradford: DAWN https://t.co/RWKEHG09Hp DEFUSE 3 https://t.co/MLEelkIcvt Neurofilament light chain post cardiac arrest https://t.co/0eI21FpVl1 NOICE study (can’t share data, sorry) MIND USA https://t.co/IT4P7Uo6HC POLAR https://t.co
Haloperidol and Ziprasidone had no effect on duration of delirium in ICU patients. Caveats: 89% patients had hypoactive delirium with RASS below 0. we cannot exclude possibility of benefit in hyperactive delirium. https://t.co/gy7x5hLmXs
RT @SummitCritCare: From prior @SummitCritCare plenary speaker @timothygirard and #WesEly from @VUMChealth, anti-psychotic therapy in sever…
From prior @SummitCritCare plenary speaker @timothygirard and #WesEly from @VUMChealth, anti-psychotic therapy in severely ill #ICU patients did not shorten #delirium duration. See their talks on our YouTube channel: https://t.co/mI5d5MhGGz https://t.co/w
RT @NIDUS_Delirium: Looking forward to listening to the upcoming @GeriPalBlog podcast with @timothygirard on antipsychotics for #delirium!…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
Looking forward to listening to the upcoming @GeriPalBlog podcast with @timothygirard on antipsychotics for #delirium!
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
RT @EWidera: What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment…
What questions should we ask @timothygirard tomorrow during our #podcast on his @NEJM article on antipsychotics for treatment of #delirium in critical illness? https://t.co/jVf9EpTdFf #geriatrics #HPM https://t.co/7o6DgHQIcx
Worthing ICU Journal Club this week discussed this - Dopamine antagonists not a panacea for delirium
今週の抄読会は、ICU入室患者のせん妄に対する抗精神病薬の効果を比較した多施設無作為化二重盲検比較試験ついての文献を、井上慎一郎先生が読みました。 結果、ハロペリドール及びジプラシドンは、偽薬と比較してせん妄の発症期間を変化させませんでした。 https://t.co/WvaDY9sSDt
RT @virenkaul: Best thing to do for #delirium in ICU? Prevent it by: ☄️Minimizing sedatives 💊regularly reviewing meds on board 🚶🏽♂️Easy…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
Thread 👇
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
RT @CritCareReviews: Excellent thread to follow for further understanding of the #MIND_USA trial. More to follow at the Critical Care Revie…
RT @timothygirard: Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: htt…
Excellent thread to follow for further understanding of the #MIND_USA trial. More to follow at the Critical Care Reviews Meeting Join the conversation in person at #CCR19 https://t.co/6aahxrDnGA
Thanks for @emcrit for pointing their followers to our recent @NEJM publication on antipsychotics for @ICU_delirium: https://t.co/r4htItyP9R
Haloperidol or ziprasidone, vs placebo, did not significantly alter the duration of #delirium in #ICU pts. #FOAMed @NEJM https://t.co/KmCJdCtQLO
ICUせん妄に対するハロペリドールの使用は患者の生存日数には関係しないという論文。ICUなど緊急時のせん妄は患者の予後を決める重大な事象だ。これらの予防や治療に適応外でハロペリドールを使用している病院も多いが考えさせられる論文だ。 https://t.co/LbYnoWdb4B
"Haloperidol and Ziprasidone for Treatment of #Delirium in Critical Illness" #hpm #palliative #care https://t.co/pbaQcAGFDJ https://t.co/o5nGflykqx
@meredithgrey89 بگین چون جدیدا ثابت شده هالوپریدول و زیپراسیدون روی دیلیریوم تاثیری نداره دچار ناامیدی شدین و جوابی نداشتین بدین :-) https://t.co/iTuzELGJGx
RT @intensivecare_c: せん妄に抗精神病薬は有効か? 急性呼吸不全またはショック+せん妄患者に対する、ハロペリドール vs ziprasidone(非定型抗精神病薬) vs プラセボの比較。 抗精神病薬を使用してもせん妄の期間は短縮しないという結果。 ht…
RT @intensivecare_c: せん妄に抗精神病薬は有効か? 急性呼吸不全またはショック+せん妄患者に対する、ハロペリドール vs ziprasidone(非定型抗精神病薬) vs プラセボの比較。 抗精神病薬を使用してもせん妄の期間は短縮しないという結果。 ht…
RT @intensivecare_c: せん妄に抗精神病薬は有効か? 急性呼吸不全またはショック+せん妄患者に対する、ハロペリドール vs ziprasidone(非定型抗精神病薬) vs プラセボの比較。 抗精神病薬を使用してもせん妄の期間は短縮しないという結果。 ht…
RT @intensivecare_c: せん妄に抗精神病薬は有効か? 急性呼吸不全またはショック+せん妄患者に対する、ハロペリドール vs ziprasidone(非定型抗精神病薬) vs プラセボの比較。 抗精神病薬を使用してもせん妄の期間は短縮しないという結果。 ht…
Compared to placebo, neither haloperidol nor ziprasidone significantly changed the duration of #delirium in #patients with acute respiratory failure or shock. Consider the study results and share with your team. Read More: https://t.co/XVo1yBPMre #Journal
RT @accpcritprn: Excellent editorial by Dr. Thomas P. Bleck on the new MIND-USA trial for anti-psychotics in ICU delirium. #critPRN https:/…
RT @iwashyna: We need to read MIND-USA, too #ICUreadings https://t.co/zp8fvCg2Gz
Study Results: Compared to placebo, neither haloperidol nor ziprasidone significantly changes the duration of #delirium in #patients with acute #respiratory failure or shock. Keep the results in mind when considering treatment options. https://t.co/XVo1yBy